洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2100044050】Does Coronavirus Disease 2019 (COVID-19) Pandemic cause a delay in the diagnosis of gastric cancer patients?- a single center study

基本信息
登记号

ChiCTR2100044050

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-03-09

临床申请受理号

/

靶点

/

适应症

Gastric cancer, 新型冠状病毒肺炎(COVID-19)

试验通俗题目

Does Coronavirus Disease 2019 (COVID-19) Pandemic cause a delay in the diagnosis of gastric cancer patients?- a single center study

试验专业题目

Does Coronavirus Disease 2019 (COVID-19) Pandemic cause a delay in the diagnosis of gastric cancer patients?- a single center study

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

The aim of this study is to analyze whether COVID-19 cause a delay in the diagnosis of the gastric cancer patients particularly in the TNM staging of the tumor, or not and to compare the number of the newly diagnosed patients with gastric cancer before and during the COVID-19 pandemic period.

试验分类
试验类型

连续入组

试验分期

其它

随机化

This is a retrospective study. No randomization needed.

盲法

N/A

试验项目经费来源

none

试验范围

/

目标入组人数

90;106

实际入组人数

/

第一例入组时间

2021-01-17

试验终止时间

1990-01-01

是否属于一致性

/

入选标准

The study included the patients diagnosed with gastric cancer during the period between March 1, 2020 and December 31, 2020 in the pandemic group at the Adana City Training and Research Hospital, Department of General Surgery, Divisions of Gastroenterological Surgery and Surgical Oncology.;

排除标准

The patients who had distant metastases and underwent chemotherapy.;

研究者信息
研究负责人姓名
试验机构

none

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

none的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品